One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial. [electronic resource]
Producer: 20120125Description: 49-58 p. digitalISSN:- 1099-1166
- Aged
- Aged, 80 and over
- Analysis of Variance
- Anticholesteremic Agents -- therapeutic use
- Anticoagulants -- therapeutic use
- Atorvastatin
- Atrial Fibrillation -- drug therapy
- Atrophy -- drug therapy
- Azetidines -- therapeutic use
- Biomarkers -- blood
- Cholesterol -- blood
- Double-Blind Method
- Ezetimibe
- Female
- Heptanoic Acids -- therapeutic use
- Humans
- Male
- Memory -- drug effects
- Memory Disorders -- drug therapy
- Neuropsychological Tests
- Pyrroles -- therapeutic use
- Temporal Lobe -- pathology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.